10 employees
CMP Therapeutics develops chitin microparticles for macrophages and dendritic cells in the nasal and respiratory tract.
2004
$5.7M
from 2 investors over 2 rounds
CMP Therapeutics Ltd. raised $2M on July 29, 2010
Investors: Inventages Venture Capital
CMP Therapeutics Ltd. raised $5.7M on October 27, 2006